
09/30/2019
Top Buys
- Name% Change
- ABBV AbbVie Inc 9.299%
- BMRN BioMarin Pharmaceut... 8.527%
- CNC Centene Corp 5.916%
- IQV IQVIA Holdings Inc 4.34%
- GILD Gilead Sciences Inc. 2.781%
HTTP://WWW.COCAPLLC.COM • SAN FRANCISCO, CA • Investment Advisor • Hedge Fund How do I update this listing?
Copernicus Capital Management is based out of San Francisco. Copernicus Capital Management is a large advisory firm with 4 clients and discretionary assets under management (AUM) of $134,243,331 (Form ADV from 2019-03-26). Their last reported 13F filing for Q3 2019 included $107,490,000 in managed 13F securities and a top 10 holdings concentration of 84.05%. Copernicus Capital Management's largest holding is Gilead Sciences Inc. with shares held of 197,916. Whalewisdom has at least 8 13F filings
09/30/2019
09/30/2019
09/30/2019
09/30/2019
09/30/2019
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
You are limited to the prior 8 quarters of 13F filings. Subscribe to WhaleWisdom to view all filing data for COPERNICUS CAPITAL MANAGEMENT, LLC
Top 20 equal-weighted holdings. Performance numbers calculated through 2019-11-14
Performance for Q3 2019: | 1.68% |
Performance Last 4 Quarters: | 0.26% |
SEC Registration as : | Large Advisory Firm |
Form of Organization: | Limited Liability Company |
Organized in: | DE |
Number of employees: | 3 |
Other Business Activities: | |
Advisor Fees/Compensation: | Percentage of assets under management,Performance-based fees |
Amount of client funds and securities: | 134,243,000 |
Total Number of Clients: | 4 |
Amount of client funds and securities by related persons: | |
Total Number of clients from related persons: | |
Disclosures: |
Name | Title | Start Date | Direct/Indirect | % Ownership | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RENDE, JOHN, WARD | MANAGING MEMBER | 04/01/2013 | Direct | 75% or more | ||||||||||||||||
|
||||||||||||||||||||
SKALING, CRAIG, DAVID | CCO/COO | 10/01/2015 | Direct | less than 5% | ||||||||||||||||
|
Name | Country | Fund Identification Number | Fund Type | Gross Asset Value | Minimum Investment | Other |
---|---|---|---|---|---|---|
BORGHESE PARTNERS, LP | United States | 805-8228670166 | Hedge Fund | 11,230,560 | 1,000,000 | |
BORGHESE PARTNERS MASTER FUND, LP | Cayman Islands | 805-9250202922 | Hedge Fund | 134,012,771 | 1,000,000 | Master Fund |
Name | Title | Start Date | Direct/Indirect | % Ownership | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RENDE, JOHN, WARD | MANAGING MEMBER | 04/01/2013 | Direct | 75% or more | ||||||||||||||||
|
||||||||||||||||||||
SKALING, CRAIG, DAVID | CCO/COO | 10/01/2015 | Direct | less than 5% | ||||||||||||||||
|
Name | Country | Fund Identification Number | Fund Type | Gross Asset Value | Minimum Investment | Other |
---|---|---|---|---|---|---|
BORGHESE PARTNERS, LP | United States | 805-8228670166 | Hedge Fund | 14,471,059 | 1,000,000 | |
BORGHESE PARTNERS MASTER FUND, LP | Cayman Islands | 805-9250202922 | Hedge Fund | 90,993,915 | 1,000,000 | Master Fund |